[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Healthcare Analytics Market: By Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics), By Application (Population Health Analytics, Financial Management, Clinical Data Management, Operations Management, Others), By Component (Hardware, Software, and Services) By End-Use (Hospitals, Clinics, and Others) and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

September 2017 | 205 pages | ID: GE7BD2C4E98EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Healthcare Analytics Market Report Description:

Healthcare analytics market report gives comprehensive outlook on Healthcare Analytics across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on healthcare analytics market gives historical, current, and future market sizes (US$ Mn) of type, application, component, end-use and geographic regions. This report studies healthcare analytics market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed healthcare analytics market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the healthcare analytics market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of healthcare analytics.

Healthcare Analytics Market:

The healthcare analytics market estimated to be valued over US$ 14,000 Mn in 2016 and expanding at a growth rate of 26 %, and projected to reach US$ XX Mn by 2023.

Dramatic change in healthcare industry has expected to fuel the healthcare analytics market.

Healthcare industry is adopting innovative technologies from the past decade. The advanced analytics can play a vital role in healthcare systems and provide insights to manage business proactively and efficiently. Moreover, analytics enables predict patient’s future health needs, which is more useful for provider and payer. Hence, most of the healthcare organizations are inclining towards healthcare analytics. For instance, electronic health records (EHR) provides patient data like history, prescriptions, personal details like contact number, email address, diagnostic test results, physician’s comments etc.

Gradual increase in healthcare expenditure is expected to witness robust growth in healthcare analytics market.

Healthcare expenditure is prime factor, which drives the healthcare analytics market. Rise in healthcare expenditure, effective hospital management strongly correlates with quality of care. Healthcare analytics able to provide insights to reduce costs, identify at-risk populations, minimize inefficiencies, and predict future healthcare needs and diagnostic tests.

North America has expected to account for major revenue share of global healthcare analytics market

U.S. healthcare analytics market is expected to expand at significant CAGR over the forecast period owing to rise in healthcare expenditure, adoption of sophisticate technologies have expected to propel the market.

The healthcare services come with a price, organizations are incentivized to seek volume business over the value business. The above model enables enhance readmissions, repeat visits, and other inefficiencies that increase cost. Analytics used to implement payment process depends on performance rather than volume, the provider would be paid for value, depends on outcomes.

Data driven models have been using to identify disease risk factors. Health Insurance Portability and Accountability Act’s (HIPAA), permits the disclosure of confidential information regarding health for research without authorization of patient.

Lack of skilled resources, limited healthcare infrastructure in developing countries, data confidentiality is the major challenges of the healthcare analytics market.

COMPETITION ASSESSMENT

Key players’ profiles in the global healthcare analytics market include:
  • Allscripts Health Solutions (U.S.)
  • Cerner Corporation (U.S.)
  • IBM Corporation (U.S.)
  • Health Catalyst (U.S.).
  • HP Development Company, L.P.(U.S.)
  • Inovalon (U.S.)
  • McKesson Corporation (U.S.)
  • Mede Analytics, Inc. (U.S.)
  • Oracle Corporation (U.S.)
  • Optum, Inc. (U.S.)
  • Verisk Analytics (U.S.)
  • SAS Institute, Inc. (U.S.)
Market players are focusing on mergers and acquisitions to improve their market position in Healthcare Analytics market.

KEY FINDINGS OF THE REPORT:
      • Healthcare analytics market is expanding at XX% CAGR over 2017 to 2023 to reach market value of US$ XX Mn by 2023
  • Based on type, predictive analytics market is expanding at highest CAGR over the forecast period.
    • Based on region type, North America is expected to account for major market share.
  • Hospitals are prime channel for surgical instruments systems distribution across the globe
    • Players focusing on expanding geographic presence to garner market opportunities in developing economies
KEY FEATURES OF THE REPORT:
  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
    • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
DETAILED SEGMENTATION

By Type
  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics
  • Others
By Application
  • Population Health Analytics
  • Financial Analytics
  • Claims Processing
  • Revenue Cycle Management (RCM)
  • Payment Integrity
  • Risk Adjustment
  • Fraud, Waste, and Abuse (FWA)
  • Clinical Analytics
  • Comparative Analytics/Comparative Effectiveness
  • Quality Improvement & Clinical Benchmarking
  • Reporting and Compliance
  • Clinical Decision Support
  • Precision Health
  • Operational and Administrative Analytics
  • Workforce Management
  • Strategic Analysis
  • Supply Chain Management
  • Others
By Component
  • Hardware
  • Software
  • Services
By End-Use
  • Hospitals
  • Clinics
  • Others
By Geography
  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • France
    • U.K
    • Italy
    • Spain
    • Russia
    • Poland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Venezuela
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • Gulf Cooperation Council (GCC) Countries
    • Israel
    • South Africa
Rest of MEA
1. RESEARCH METHODOLOGY

1.1. Secondary and Primary research
  1.1.1. Secondary Sources
  1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms

2. SCOPE OF STUDY

2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study

3. EXECUTIVE SUMMARY

4. GLOBAL HEALTHCARE ANALYTICS MARKET DYNAMIC FACTORS

4.1. Drivers
  4.1.1. Economic Drivers
  4.1.2. Demand Side Drivers
  4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends

5. UNIQUE FEATURES OF THE REPORT

5.1. Competition analysis
  5.1.1. Dash board of top players
  5.1.2. Financial Analysis
  5.1.3. Product & Services
  5.1.4. Key Developments
  5.1.5. Major Strategies
  5.1.6. SWOT Analysis
5.2. Technological advancements in healthcare analytics market
5.3. Recent investments in the industry
5.4. Regulatory landscape
  5.4.1. U.S.
  5.4.2. Europe
5.5. PESTLE analysis
5.6. Porter’s analysis

6. GLOBAL HEALTHCARE ANALYTICS MARKET, BY TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Descriptive Analytics
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Predictive Analytics
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.3. Prescriptive Analytics
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.4. Others
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

7. GLOBAL HEALTHCARE ANALYTICS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 – 2023

7.1. Population Health Analytics
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. Financial Analytics
    7.2.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
    7.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.2.2. Claims Processing
      7.2.2.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.2.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.2.3. Revenue Cycle Management (RCM)
      7.2.3.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.2.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.2.4. Payment Integrity
      7.2.4.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.2.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.2.5. Risk Adjustment
      7.2.5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.2.5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.2.6. Fraud, Waste, and Abuse (FWA)
      7.2.6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.2.6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.3. Clinical Analytics
  7.3.1. Comparative Analytics/Comparative Effectiveness
      7.3.1.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.3.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.3.2. Quality Improvement & Clinical Benchmarking
      7.3.2.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.3.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.3.3. Reporting and Compliance
      7.3.3.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.3.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.3.4. Clinical Decision Support
      7.3.4.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.3.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.3.5. Precision Health
      7.3.5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.3.5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.4. Operational and Administrative Analytics
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.4.3. Workforce Management
      7.4.3.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.4.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.4.4. Strategic Analysis
      7.4.4.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.4.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
  7.4.5. Supply Chain Management
      7.4.5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
      7.4.5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.5. Others
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

8. GLOBAL HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Hardware
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Software
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Services
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

9. GLOBAL HEALTHCARE ANALYTICS MARKET, BY END-USE, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. Hospitals
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.2. Clinics
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.3. Others
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

10. HEALTHCARE ANALYTICS MARKET FORECAST, BY REGION ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. North America Healthcare Analytics Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  10.1.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.1.1.1. Descriptive Analytics
    10.1.1.2. Predictive Analytics
    10.1.1.3. Prescriptive Analytics
    10.1.1.4. Others
  10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.1.2.1. Population Health Analytics
    10.1.2.2. Financial Analytics
      10.1.2.2.1. Claims Processing
      10.1.2.2.2. Revenue Cycle Management (RCM)
      10.1.2.2.3. Payment Integrity
      10.1.2.2.4. Risk Adjustment
      10.1.2.2.5. Fraud, Waste, and Abuse (FWA)
    10.1.2.3. Clinical Analytics
      10.1.2.3.1. Comparative Analytics/Comparative Effectiveness
      10.1.2.3.2. Quality Improvement & Clinical Benchmarking
      10.1.2.3.3. Reporting and Compliance
      10.1.2.3.4. Clinical Decision Support
      10.1.2.3.5. Precision Health
    10.1.2.4. Operational and Administrative Analytics
      10.1.2.4.1. Workforce Management
      10.1.2.4.2. Strategic Analysis
      10.1.2.4.3. Supply Chain Management
    10.1.2.5. Others
  10.1.3. Component Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.1.3.1. Hardware
    10.1.3.2. Software
    10.1.3.3. Services
  10.1.4. End use Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.1.4.1. Hospitals
    10.1.4.2. Clinics
    10.1.4.3. Others
  10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.1.5.1. U.S.
    10.1.5.2. Canada
10.2. Europe Healthcare Analytics Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  10.2.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.2.1.1. Descriptive Analytics
    10.2.1.2. Predictive Analytics
    10.2.1.3. Prescriptive Analytics
    10.2.1.4. Others
  10.2.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.2.2.1. Population Health Analytics
    10.2.2.2. Financial Analytics
      10.2.2.2.1. Claims Processing
      10.2.2.2.2. Revenue Cycle Management (RCM)
      10.2.2.2.3. Payment Integrity
      10.2.2.2.4. Risk Adjustment
      10.2.2.2.5. Fraud, Waste, and Abuse (FWA)
    10.2.2.3. Clinical Analytics
      10.2.2.3.1. Comparative Analytics/Comparative Effectiveness
      10.2.2.3.2. Quality Improvement & Clinical Benchmarking
      10.2.2.3.3. Reporting and Compliance
      10.2.2.3.4. Clinical Decision Support
      10.2.2.3.5. Precision Health
    10.2.2.4. Operational and Administrative Analytics
      10.2.2.4.1. Workforce Management
      10.2.2.4.2. Strategic Analysis
      10.2.2.4.3. Supply Chain Management
    10.2.2.5. Others
  10.2.3. Component Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.2.3.1. Hardware
    10.2.3.2. Software
    10.2.3.3. Services
  10.2.4. End use Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.2.4.1. Hospitals
    10.2.4.2. Clinics
    10.2.4.3. Others
  10.2.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.2.5.1. Germany
    10.2.5.2. UK
    10.2.5.3. France
    10.2.5.4. Spain
    10.2.5.5. Italy
    10.2.5.6. Russia
    10.2.5.7. Poland 10.2.5.8. Rest of Europe
10.3. Asia-Pacific Healthcare Analytics Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  10.3.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.3.1.1. Descriptive Analytics
    10.3.1.2. Predictive Analytics
    10.3.1.3. Prescriptive Analytics
    10.3.1.4. Others
  10.3.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.3.2.1. Population Health Analytics
    10.3.2.2. Financial Analytics
      10.3.2.2.1. Claims Processing
      10.3.2.2.2. Revenue Cycle Management (RCM)
      10.3.2.2.3. Payment Integrity
      10.3.2.2.4. Risk Adjustment
      10.3.2.2.5. Fraud, Waste, and Abuse (FWA)
    10.3.2.3. Clinical Analytics
      10.3.2.3.1. Comparative Analytics/Comparative Effectiveness
      10.3.2.3.2. Quality Improvement & Clinical Benchmarking
      10.3.2.3.3. Reporting and Compliance
      10.3.2.3.4. Clinical Decision Support
      10.3.2.3.5. Precision Health
    10.3.2.4. Operational and Administrative Analytics
      10.3.2.4.1. Workforce Management
      10.3.2.4.2. Strategic Analysis
      10.3.2.4.3. Supply Chain Management
    10.3.2.5. Others
  10.3.3. Component Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.3.3.1. Hardware
    10.3.3.2. Software
    10.3.3.3. Services
  10.3.4. End use Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.3.4.1. Hospitals
    10.3.4.2. Clinics
    10.3.4.3. Others
  10.3.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.3.5.1. Japan
    10.3.5.2. China
    10.3.5.3. India
    10.3.5.4. ASEAN
    10.3.5.5. Australia & New Zealand 10.3.5.6. Rest of Asia-Pacific
10.4. Latin America Healthcare Analytics Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  10.4.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.4.1.1. Descriptive Analytics
    10.4.1.2. Predictive Analytics
    10.4.1.3. Prescriptive Analytics
    10.4.1.4. Others
  10.4.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.4.2.1. Population Health Analytics
    10.4.2.2. Financial Analytics
      10.4.2.2.1. Claims Processing
      10.4.2.2.2. Revenue Cycle Management (RCM)
      10.4.2.2.3. Payment Integrity
      10.4.2.2.4. Risk Adjustment
      10.4.2.2.5. Fraud, Waste, and Abuse (FWA)
    10.4.2.3. Clinical Analytics
      10.4.2.3.1. Comparative Analytics/Comparative Effectiveness
      10.4.2.3.2. Quality Improvement & Clinical Benchmarking
      10.4.2.3.3. Reporting and Compliance
      10.4.2.3.4. Clinical Decision Support
      10.4.2.3.5. Precision Health
    10.4.2.4. Operational and Administrative Analytics
      10.4.2.4.1. Workforce Management
      10.4.2.4.2. Strategic Analysis
      10.4.2.4.3. Supply Chain Management
    10.4.2.5. Others
  10.4.3. Component Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.4.3.1. Hardware
    10.4.3.2. Software
    10.4.3.3. Services
  10.4.4. End use Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.4.4.1. Hospitals
    10.4.4.2. Clinics
    10.4.4.3. Others
  10.4.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.4.5.1. Brazil
    10.4.5.2. Mexico
    10.4.5.3. Argentina
    10.4.5.4. Venezuela
    10.4.5.5. Rest of Latin America
10.5. Middle East & Africa (MEA) Healthcare Analytics Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  10.5.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.5.1.1. Descriptive Analytics
    10.5.1.2. Predictive Analytics
    10.5.1.3. Prescriptive Analytics
    10.5.1.4. Others
  10.5.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.5.2.1. Population Health Analytics
    10.5.2.2. Financial Analytics
      10.5.2.2.1. Claims Processing
      10.5.2.2.2. Revenue Cycle Management (RCM)
      10.5.2.2.3. Payment Integrity
      10.5.2.2.4. Risk Adjustment
      10.5.2.2.5. Fraud, Waste, and Abuse (FWA)
    10.5.2.3. Clinical Analytics
      10.5.2.3.1. Comparative Analytics/Comparative Effectiveness
      10.5.2.3.2. Quality Improvement & Clinical Benchmarking
      10.5.2.3.3. Reporting and Compliance
      10.5.2.3.4. Clinical Decision Support
      10.5.2.3.5. Precision Health
    10.5.2.4. Operational and Administrative Analytics
      10.5.2.4.1. Workforce Management
      10.5.2.4.2. Strategic Analysis
      10.5.2.4.3. Supply Chain Management
    10.5.2.5. Others
  10.5.3. Component Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.5.3.1. Hardware
    10.5.3.2. Software
    10.5.3.3. Services
  10.5.4. End use Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.5.4.1. Hospitals
    10.5.4.2. Clinics
    10.5.4.3. Others
  10.5.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.5.5.1. Gulf Cooperation Council (GCC) Countries
    10.5.5.2. Israel
    10.5.5.3. South Africa
    10.5.5.4. Rest of MEA

11. COMPETITION LANDSCAPE

11.1. Strategic Dashboard of Top Market Players
11.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  11.2.1. Allscripts Health Solutions (U.S.)
  11.2.2. Cerner Corporation (U.S.)
  11.2.3. IBM Corporation (U.S.)
  11.2.4. Health Catalyst (U.S.).
  11.2.5. HP Development Company, L.P.(U.S.)
  11.2.6. Inovalon (U.S.)
  11.2.7. McKesson Corporation (U.S.)
  11.2.8. Mede Analytics, Inc. (U.S.)
  11.2.9. Oracle Corporation (U.S.)
  11.2.10. Optum, Inc. (U.S.)
  11.2.11. Verisk Analytics (U.S.)
  11.2.12. SAS Institute, Inc. (U.S.)


More Publications